GBCS — Selectis Health Share Price
0.000.00%
Last trade - 00:00- $6.44m
- $42.87m
- $36.78m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 6.14 | ||
| Price to Sales | 0.13 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -35.9% | ||
| Return on Equity | n/a | ||
| Operating Margin | -20.96% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 6.93 | 20.93 | 29.29 | 40.6 | 36.78 | n/a | n/a | 58.97% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Selectis Health, Inc. acquires, develops, leases, manages, and disposes of healthcare real estate, provides financing to healthcare providers, and provides healthcare operations through its wholly owned subsidiaries. Its portfolio is comprised of investments in three healthcare segments: senior housing, including independent and assisted living, and post-acute/skilled nursing facilities. The Company owns and operates, through wholly owned subsidiaries, Assisted Living Facilities, Independent Living Facilities, and Skilled Nursing Facilities across the South and Southeastern portions of the United States. Assisted Living Facilities are licensed care facilities that provide personal care services, support, and housing for those who need help with activities of daily living yet require limited medical care. Independent Living Facilities are designed to meet the needs of seniors who choose to live in an environment surrounded by their peers.
Directors
- Christopher Barker PRE (53)
- Lance Baller CEO (47)
- Brandon Thall CFO (37)
- Clifford Neuman SEC (72)
- Adam Desmond IND (50)
- Last Annual
- December 31st, 2023
- Last Interim
- March 31st, 2024
- Incorporated
- August 6th, 1978
- Public Since
- June 25th, 2001
- No. of Shareholders
- 93
- No. of Employees
- 574
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 3,067,059
- Address
- 8480 E. Orchard Road, Suite 4900, GREENWOOD VILLAGE, 80503
- Web
- https://www.selectis.com
- Phone
- +1 7206800808
- Contact
- Jackie Keshner
- Auditors
- Marcum LLP
Upcoming Events for GBCS
Q2 2025 Selectis Health Inc Earnings Release
Q3 2024 Selectis Health Inc Earnings Release
Similar to GBCS
4Cable TV International
Pink Sheets on Nasdaq
Abattis Bioceuticals
Pink Sheets on Nasdaq
Accelera Innovations
Pink Sheets on Nasdaq
ACI Global
Pink Sheets on Nasdaq
Quantum Medical Transport
Pink Sheets on Nasdaq
FAQ
What is the Selectis Health share price?
As of Today at 17:11 UTC, shares in Selectis Health are trading at $1.50. This share price information is delayed by 15 minutes.
How has the Selectis Health share price performed this year?
Shares in Selectis Health last closed at $1.50 and the price had moved by -68.42% over the past 365 days. In terms of relative price strength the Selectis Health share price has underperformed the S&P500 Index by -73.5% over the past year.
What are the analyst and broker recommendations for Selectis Health?
There is no consensus recommendation for this security.
What is the Selectis Health dividend yield?
Selectis Health does not currently pay a dividend.
Does Selectis Health pay a dividend?
Selectis Health does not currently pay a dividend.
When does Selectis Health next pay dividends?
Selectis Health does not currently pay a dividend.
How do I buy Selectis Health shares?
To buy shares in Selectis Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Selectis Health?
As of the previous close price of $1.50, shares in Selectis Health had a market capitalisation of $4.60m.
Where are Selectis Health shares listed?
Here are the trading details for Selectis Health:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: GBCS
What kind of share is Selectis Health?
Based on an overall assessment of its quality, value and momentum Selectis Health is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Selectis Health share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Selectis Health share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Selectis Health. Over the past six months, its share price has underperformed the S&P500 Index by -66.04%.
As of the last closing price of $1.50, shares in Selectis Health were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Selectis Health PE Ratio?
The Selectis Health PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $1.50.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Selectis Health?
Selectis Health's management team is headed by:
- Christopher Barker - PRE
- Lance Baller - CEO
- Brandon Thall - CFO
- Clifford Neuman - SEC
- Adam Desmond - IND